安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- What’s new in KRAS mutation research? - MD Anderson Cancer Center
The most frequently mutated of these oncogenic driver genes, called KRAS, is associated with some of the most fatal cancer types: lung, pancreatic and colorectal cancers
- KRAS mutation: from undruggable to druggable in cancer
As the most frequently mutated oncogene, Kirsten rat sarcoma viral oncogene homologue (KRAS) has attracted substantial attention The understanding of KRAS is constantly being updated by numerous
- KRAS gene - MedlinePlus
The KRAS gene provides instructions for making a protein called K-Ras that is part of a signaling pathway known as the RAS MAPK pathway The protein relays signals from outside the cell to the cell's nucleus
- KRAS Mutations in Solid Tumors: Characteristics, Current Therapeutic . . .
Kristen rat sarcoma (KRAS) gene is one of the most common mutated oncogenes in solid tumors Yet, KRAS inhibitors did not follow suit with the development of targeted therapy, for the structure of KRAS has been considered as being implausible to target for decades
- Uniquely engineered KRAS-targeted cancer drug found to be effective in . . .
Some KRAS mutations occur at a higher frequency in certain cancer subtypes: the G12V mutation is a common KRAS mutation amongst lung (22%), colon (22%) and pancreatic (30%) cancers Starting in the lab, the researchers set out to identify a promising cell surface receptor that could selectively deliver their RNA molecules into the tumor cells
- KRAS Oncoprotein Signaling in Cancer | New England Journal of Medicine
Recent studies provide new insights into signaling by mutant KRAS, inhibitors of which have provided modest benefits for patients
- What Is the KRAS-Variant? How It Impacts Cancer Treatment - MiraKind
The KRAS-variant is a unique biomarker which provides a new explanation for the genetic cause of cancer in families with a strong history of cancer
- KRAS - Know Your Biomarker
All patients with stage IV metastatic colorectal cancer should have KRAS biomarker testing KRAS is a gene involved in controlling cell growth and cell survival 40% of colorectal cancers have a KRAS mutation Colorectal cancer with wild-type (non-mutant) KRAS may be treated with EGFR inhibitors
|
|
|